What should a patient tell the anesthesia team before surgery or sedation while using a compounded GLP-1?

Tell your anesthesia team you use a compounded GLP-1, your dose, and the date of your last injection to prevent serious complications during surgery.

Why Anesthesia Teams Need to Know About Your GLP-1 Use

GLP-1 receptor agonists, including semaglutide and tirzepatide, work in part by delaying gastric emptying. This means food and liquids stay in your stomach for a longer period after you eat. This effect is a key mechanism for how these medications help with weight management and blood sugar control.

This delayed gastric emptying poses a specific risk during sedation or general anesthesia. Even if you have followed standard preoperative fasting instructions (e.g., no food or drink after midnight), your stomach may not be empty. This condition is often referred to as having a "full stomach."

The primary danger of a full stomach during anesthesia is pulmonary aspiration. If stomach contents are regurgitated while you are sedated, they can be inhaled into the lungs. This can cause serious complications, including pneumonia, lung injury, and respiratory failure.

Full disclosure is especially vital when using compounded medications. Compounded GLP-1s are not FDA-approved, meaning their potency and formulation can differ from brand-name drugs. Providing complete information helps the anesthesia team make the safest possible plan for your specific situation.

What Specific Information to Provide

Be precise about the medication you are taking. State clearly that you are on a "compounded semaglutide" or "compounded tirzepatide" from a physician-supervised program. Do not use brand names like Ozempic or Wegovy, as this would be inaccurate and could mislead the team.

Inform them of your current dosage (e.g., 1.0 mg), the frequency of administration (e.g., weekly), and the exact date and time of your last injection. This timing is critical for the anesthesiologist to assess the potential level of gastric delay.

Share the reason you are taking the medication, whether for type 2 diabetes or for weight management. This clinical context helps the team understand your overall health profile. Also, list all other medications and supplements you take.

Report any gastrointestinal side effects you have experienced, such as nausea, vomiting, abdominal bloating, or severe constipation. These symptoms may suggest a more significant delay in gastric emptying and could influence the anesthetic plan.

Current Anesthesia Guidelines for GLP-1 Users

In 2023, the American Society of Anesthesiologists (ASA) issued consensus-based guidance due to the increased risk of pulmonary aspiration associated with GLP-1 agonists. Your anesthesia team will likely follow these or similar institutional protocols.

For patients taking a GLP-1 agonist daily, the ASA suggests holding the dose on the day of the procedure or surgery. This helps minimize the acute effects on your gastric motility just before anesthesia is administered.

For patients on a weekly injection schedule, the guidance recommends holding the medication for one week before the procedure. For example, if you normally take your injection on a Tuesday, you would skip that dose the week of your surgery.

If you did not hold your medication or if you are experiencing significant GI symptoms, the team may need to take extra precautions. They might treat you as a "full stomach" patient, consider using ultrasound to check your stomach contents, or, if the procedure is elective, discuss postponing it to ensure your safety.

Compounded GLP-1s and Surgical Planning

It is crucial to remember that compounded drugs are not FDA-approved. They are prepared in licensed U.S. pharmacies to meet the specific needs of a patient under a physician's prescription, but they have not undergone the rigorous FDA testing for safety, efficacy, and consistent manufacturing that brand-name drugs have.

Because of this potential for variability, your surgical team may take a more cautious approach. The effects of a compounded formulation on gastric emptying may not be as predictable as those of an FDA-approved product. Transparency is your most important tool for ensuring a safe outcome.

Communicate with all parties involved well in advance. Discuss your upcoming surgery with your prescribing provider and your surgeon as soon as it is scheduled. This allows for a coordinated plan for holding your medication and managing your care before and after the procedure.

For more information on navigating healthcare conversations, explore the resources available in other GOAL.MD Answers. Open dialogue with every member of your care team ensures that all aspects of your health are considered, leading to better and safer medical outcomes.

Bottom Line

Proactively informing your surgeon and anesthesia team about your use of a compounded GLP-1 is a critical step for your safety. Do not assume it is already in your chart or that it is not relevant. Make it a point to discuss it during your preoperative consultation.

Be prepared to share the drug's name (compounded semaglutide/tirzepatide), your dose, the timing of your last dose, and a description of any gastrointestinal symptoms. This information is not optional; it is essential for the anesthesia team to assess your aspiration risk.

Always follow the specific instructions given to you by the anesthesia provider regarding fasting and holding your medication. These instructions supersede any general advice and are tailored to your personal health status and the planned procedure.

This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare providers for any medical concerns.

Drafted by the GOAL.MD Authority Engine and approved editorially by GOAL.MD staff. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.